S&P also affirmed the following ratings on CHOP’s bonds:
- “AA” long-term rating on its series 2014 fixed-rate revenue bonds
- “AA” long-term rating on its series 2011C fixed-rate revenue bonds
- “AA” long-term rating on its series 2011D fixed-rate revenue bonds
- “AA” long-term rating on its series 2007A fixed-rate revenue bonds
- “AA/A-1+” rating on its series 2011A variable-rate demand bonds
- “AA/A-1+” rating on its series 2011B variable-rate demand bonds
- “AA/A-1+” rating on its series 2005A variable-rate demand bonds
- “AA/A-1+” rating on its series 2002A variable-rate demand bonds
- “AA/A-1+” rating on its series 2002B variable-rate demand bonds
“The ‘AA’ rating reflects our view of such factors as CHOP’s historically good volume growth, very solid market position, healthy maximum annual debt service coverage, strong unrestricted reserves and excellent fundraising record,” said S&P analyst Suzie Desai.
The outlook is stable, reflecting S&P Global Ratings’ opinion CHOP will maintain its leading market share and overall ability to generate good cash flow through the expansion of its services and reach.
More articles on healthcare finance:
Decreased funding prompts closure of 4 Planned Parenthood clinics in Iowa
Gaffey Healthcare appoints CIO: 3 notes
Avadyne Health names Jayson Yardley CEO
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.